Hepatitis C in Poland in 2016 / Wirusowe zapalenie wątroby typu C w Polsce w 2016 roku
Journal Title: Przegląd Epidemiologiczny - Year 2018, Vol 72, Issue 2
Abstract
INTRODUCTION. In 2016, the World Health Organization implemented a Global Strategy to eliminate viral hepatitis. For Hepatitis C, the goals of this Strategy include increased harm reduction coverage, improved safety of medical procedures and an increase the percentage of people diagnosed and treated. OBJECTIVE. This article aims are evaluating the epidemiological situation of HCV infections in Poland in 2016 in reference to the data from previous years. MATERIAL AND METHODS. Analysis of epidemiological situation of hepatitis C in Poland in 2016 was carried out on case-based data collected through routine surveillance system. Data on hepatitis C mortality from the Demographic Surveys and Labour Market Department of the Central Statistical Office were also included. RESULTS. In 2016, a total of 4,261 cases were reported. Diagnosis rate was 11.09 per 100,000, on the similar level as in 2015 (1% decrease), but in comparison to the median for the years 2010-2014 it increased by 88%. The most common possible route of HCV infection were medical procedures accounting for 69.8% of all cases and for 58.2% of acute hepatitis C virus infection cases. In 2016, 224 deaths due to hepatitis C were registered. In 2016, a hepatitis C outbreak was reported in małopolskie voivodeship (11 patients of the Hemato-oncolology Department, 129 people exposed). CONCLUSIONS. The increase of HCV diagnosis rate, which has been reported for last three years, is probably a consequence of improved the surveillance, including mandatory reporting of positive laboratory results, but also increased availability of HCV laboratory screening. Medical exposures are still an important route of transmission of HCV in Poland.
Authors and Affiliations
Karolina Zakrzewska, Małgorzata Stępień, Katarzyna Szmulik, Magdalena Rosińska
Keywords
Related Articles
- EP ID EP625289
- DOI -
- Views 73
- Downloads 0
Epidemiological situation of tuberculosis in the world based on a report of the World Health Organization 2013
The epidemiological situation of tuberculosis is regionally diverse and dynamically changing. It is related not only to the health status of people but also to the organization of health care, financial possibilities, an...
Rapid appraisal of road-safety environment around educational institutions of Mangaluru city, South India
INTRODUCTION: Road traffic accidents (RTA) are the biggest killers according to the Global Status Report on Road Safety. OBJECTIVE: The objective of the present study was to assess the road safety in the vicinity of the...
Discontinuation of tenofovir due to nephrotoxicity: insight into 12 years of clinical practice / Odstawienie tenofowiru z powodu nefrotoksyczności: doświadczenia z 12 lat praktyki klinicznej
INTRODUCTION. Chronic kidney disease is a significant cause of morbidity and mortality among patients infected with human immunodeficiency virus (HIV). Tenofovir disoproxil fumarate (TDF) is widely used as the part of co...
Borrelia miyamotoi - new etiologic agent of neuroborreliosis? / Borrelia miyamotoi – nowy czynnik etiologiczny neuroboreliozy?
Borrelia miyamotoi spirochetes discovered in Ixodes persulcatus ticks in Japan, in 1994 and documented in ticks and rodents in moderate climate zone of northern hemisphere. They belong to tick-borne relapsing fever group...
Epidemiological characteristics and access to end-stage liver disease care for HIV-positive patients with HCV and/or HBV coinfections in Central/Eastern European and neighboring countries – data from the ECEE network / Charakterystyka epidemiologiczna i dostęp do opieki w schyłkowej niewydolności wątroby u pacjentów zakażonych HIV współzakażonych HCV i/lub HBV w krajach Europy środkowej/wschodniej
OBJECTIVES. There is currently an urgent need to harmonize hepatitis standards of care for HIV-positive patients across Europe. The HIV epidemic in Central and Eastern Europe has often been driven by injecting drug use,...